China’s WuXi explores sale of pharma operations as US restrictions loom: FT
October 3, 2024
[ad_1] WUXI AppTec and WuXi Biologics are planning to sell some of their operations after the Chinese biotech companies were targeted by the US on national security grounds, the Financial...
